NextPlat Corp is a global e-commerce and healthcare services company operating through two reportable segments: e-Commerce Operations and Healthcare Operations. The e-commerce segment provides satellite-enabled communication products and services, including satellite phones, tracking devices, broadband terminals, and IoT connectivity solutions for remote or infrastructure-limited environments. These services are delivered via proprietary websites and third-party marketplaces such as Amazon, Alibaba, and Walmart, serving consumers, enterprises, and government organizations internationally. The healthcare segment offers retail pharmacy services, 340B program management, long-term care services, and AI-powered healthcare analytics and data solutions. The company operates through subsidiaries including Global Telesat Communications Ltd, Orbital Satcom Corp, Outfitter Satellite Inc, PharmcoRx, and Florida Sunshine Brands LLC. NextPlat partners with satellite network operators such as Iridium, Globalstar, and Starlink, and serves as the exclusive distributor of OPKO’s human and animal healthcare products in China. The company also markets its own Florida Sunshine brand of liposomal vitamins and nutritional supplements.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Internet Content & Information Homepage nextplat.com
Sector Communication Services IR page ir.nextplat.com
Tags
satellite communications, iot connectivity, asset tracking, retail pharmacy, 340b program management, healthcare analytics, e-commerce distribution, emergency beacons, broadband terminals, nutritional supplements, Global Telesat Communications Ltd, Orbital Satcom Corp, Outfitter Satellite Inc, PharmcoRx, Florida Sunshine Brands LLC, GTCTrack, OPKO, Iridium, Globalstar, Starlink, Amazon, Alibaba, Walmart, Mercado Libre, OnBuy, Tmall, JD
Press page —

Metrics

Valuation  
Market cap $ 23.51M
Market cap (USD) $ 23.51M
P/E -8.77
PEG —
P/BV 1.49
P/S 0.52
P/OCF -9.93
P/FCF -9.48
Dividend yield —
Turnover / mcap —
Returns  
ROE -47.6%
ROI -55.0%
ROIC -35.5%
Profit margin -19.3%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 5.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 34
Quality score -64.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Revenue 54.322M 65.483M 37.756M 11.71M 7.74M 5.69M 5.87M 5.727M 6.005M 4.699M 3.951M 8.41K — — — — 313.66K 456.269K —
Net profit -10.463M -14.025M -3.778M -9.161M -8.108M -2.763M -1.38M -1.195M -3.939M -2.59M -2.064M -411.234K 624.118K -4.811M -8.722M -11.579M — -5.747M -6.053M
Free cash flow -6.201M -5.653M -4.243M -4.317M -4.321M -871.883K -729.397K -620.516K -348.438K -1.07M -711.791K — — — — -829.512K -717.479K -2.174M -1.33M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Share price 0.53 1.08 1.65 1.26 3.22 — — — — — — — — — — — — — —
Price performance 12m -0.51 -0.35 0.31 -0.61 — — — — — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 96,758 294,495 170,526 244,353 177,031 349,836 383,786 8.92M 4.9M 4.01M
↳ YoY growth -17.1% +204.4% -42.1% +43.3% -27.6% +97.6% +9.7% +2,225.0% -45.1% -18.0%
↳ 5y CAGR +96.2% +8.7% +29.3% +5.4% +120.7% +82.1% +86.7%
Borrowings, current (USD) — — — — 0.00 19,763 — — — —
Lease liabilities (USD) — — — 80,857 52,699 19,763 858,555 1.48M 847,000 199,000
Cash and deposits (USD) 114,733 233,326 142,888 75,362 728,762 17.3M 18.9M 26.3M 20M 13.7M
Intangible assets (USD) 250,000 225,000 200,000 125,000 100,000 75,000 50,001 14.4M 524,000 422,000
Right-of-use assets (USD) — — — 83,679 55,606 22,643 854,862 1.57M 812,000 189,000
Net debt (borrowings + leases - cash) (USD) — — — — -676,063 -17.2M — — — —
Cash flow detail
Operating cash flow (USD) -1.04M -315,245 -590,185 -659,203 -836,980 -4.09M -3.6M -3.6M -5.46M -6.13M
Purchases of property, plant and equipment (USD) -26,448 -33,193 -30,331 -70,194 -34,903 -229,307 -715,591 -647,000 -189,000 -71,000
Change in receivables (cash effect) (USD) 19,960 -197,737 123,970 -73,827 67,322 -172,805 -33,950 -3.45M 5.34M 383,000
Change in inventories (cash effect) (USD) -83,749 2,372 63,872 -97,274 4,876 -658,274 -266,916 -2.22M 12,000 1.46M
Change in payables (cash effect) (USD) -50,827 365,475 18,777 289,751 -111,616 10,741 454,752 3.23M -6.04M 1.17M
Share buybacks (cash effect) (USD) — — — — — — — — 0.00 -100,000
Interest paid (cash effect) (USD) — — — -20,270 — -143,234 -10,842 -531,000 -81,000 -64,000
Income taxes paid (cash effect) (USD) -3,898 -6,413 -5,099 — — -38,615 -10,069 0.00 -156,000 -35,000
Share-based compensation (USD) 190,000 600,000 219,518 219,518 830,900 3.76M 2.97M 5.4M 1.6M 600,000
Operating cash flow before change in receivables (USD) -1.06M -117,508 -714,155 -585,376 -904,302 -3.92M -3.57M -147,000 -10.8M -6.51M
Free cash flow (OCF - PPE - intangibles) (USD) -1.07M -348,438 -620,516 -729,397 -871,883 -4.32M -4.32M -4.24M -5.65M -6.2M
Income detail
Research and development expense (USD) 0.00 0.00 0.00 — 0.00 0.00 — — — —
Total comprehensive income (USD) — -3.91M -1.2M -1.38M -2.8M -8.06M -9.2M -12.4M -23.1M -10.5M
Comprehensive income to owners (USD) — -3.91M -1.2M -1.38M -2.8M -8.06M -9.2M -12.4M -23.1M -10.5M
Provision for credit losses (USD) — — — — — — 0.00 47,000 -131,000 -101,000
Credit cost ratio (credit losses / average receivables) (%) — — — — — — 0.0% 1.0% 1.9% 2.3%
Reported Apr 7, 2017 Mar 29, 2019 Mar 29, 2019 May 15, 2020 Mar 31, 2022 Mar 31, 2022 Apr 11, 2024 Mar 24, 2025 Mar 31, 2026 Mar 31, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pharmacy Footprint

HALLANDALE BEACH, FL – November 12, 2026 – NextPlat Corp (NASDAQ: NXPL) (“NextPlat” or the “Company”), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced operating results for the third quarter ended September 30, 2026.

“Our third quarter results reflect continued year-over-year improvement across the business, driven by the refocusing of our healthcare operations on high-value, high-margin services designed to deliver consistent bottom-line results in what remains a dynamic market,” said David Phipps, Chief Executive Officer and President of NextPlat Corp. “Our focus remains on growth and profitability through our differentiated, high-value healthcare services and expanding community pharmacy network, including our new Scott’s location near Pensacola and a new pharmacy in Jacksonville, supported by a more efficient operating structure.

October 22, 2026 8:01am EDT

VendRx kiosks could expand PharmcoRx's reach through clinic partnerships, creating new, scalable opportunities for incremental prescription volumes

HALLANDALE BEACH, Fla., Oct. 22, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced that its wholly owned pharmacy subsidiary, PharmcoRx

, intends to launch automated prescription dispensing to select customer clinics and facilities with VendRx

 kiosks.

The VendRx kiosks will be installed in a healthcare provider's location as part of the contracted pharmacy services provided by PharmcoRx. Once installed, patients can quickly and conveniently pick up their prescriptions onsite immediately after their appointments with their care givers following patient consultation with a PharmcoRx pharmacist. Initial deployments are planned for later in the fourth quarter of 2026 with a wider rollout expected throughout 2027.

Every year in the U.S., a large percentage of prescriptions are never filled after a patient leaves their doctor's office. A contributing factor to patients failing to pick-up their prescribed medication is the fact that large retail chains continue closing pharmacies, resulting in many individuals finding themselves in a community without convenient pharmacy services, known as "pharmacy deserts." Even where a provider may be nearby, if it does not offer high-touch services such as at home delivery, the trip from the clinic to the pharmacy counter can be inconvenient, causing delays and frustration. Each unfilled prescription contributes to poor patient medication adherence, creating a missed opportunity for a better health outcome and adding avoidable increased healthcare system costs.

VendRx removes this barrier by placing the pharmacy at the point of care. Already operating in U.S. healthcare settings, VendRx reports approximately 80% formulary coverage per deployment which could help more patients leave their appointments with their prescribed medications in hand. The VendRx platform has completed more than 90,000 successful dispenses since inception, with no wrong-medication releases reported to VendRx (source: VendRx internal dispensing records and incident reporting history, through October 19th, 2026).

"The introduction of automated dispensing aligns with our focus on utilizing novel technologies and patient-focused high touch services to enhance care and convenience. This program is designed to open an additional prescription channel for PharmcoRx through clinics, bringing our pharmacy services closer to patients while supporting new provider relationships. With VendRx, each deployed kiosk is supported by our pharmacists who are available to every patient, so clinics get the speed of automation together with the care and oversight of a full-service pharmacy," said Birute Norkute, VP of Healthcare Operations at PharmcoRx. "As we have seen with our personalized prescription delivery services for patients, we believe automated onsite dispensing can be another valuable option, supporting our clinic partners with a proven, pharmacist-verified way to put prescriptions into a patient's hands, contributing to improved adherence and outcomes."

"PharmcoRx shares our conviction that medication access belongs at the point of care. Together, we're advancing a new pharmacy model that brings treatment to the moment of diagnosis—at scale. We're especially excited about what this means for patients and their healthcare providers," added Russell McKee, CEO, VendRx Inc.

Onsite automated prescription dispensing programs can benefit every healthcare stakeholder:

  • Clinics gain a modern, convenient new service that sets them apart, helps them attract and retain patients and could create a new revenue opportunity. It runs within existing workflows, with no extra staff and no on-site pharmacy to build.

  • Patients can start medication treatments right away, which matters most for acute conditions and supports better adherence for ongoing care.

  • For PharmcoRx, every clinic partnership expands its reach and prescription base.

Point-of-care dispensing is gaining momentum as evidenced by Amazon Pharmacy's launch of in-office prescription kiosks at One Medical clinics in late 2025. With VendRx, PharmcoRx can offer the same convenience to independent clinics and providers in its network.

October 13, 2026 8:01am EDT

New Jacksonville location expands PharmcoRx's statewide network with contracted services for 340B providers, long-term care facilities and specialty pharmacy patients

HALLANDALE BEACH, Fla. and JACKSONVILLE, Fla., Oct. 13, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced the opening of a new PharmcoRx

 community pharmacy in Jacksonville, Florida.

(PRNewsfoto/NextPlat Corp.)

Located at 3604 University Blvd South, Suite 102, the new pharmacy is directly across from the HCA Florida Memorial Hospital with multiple specialty medical practices and healthcare service providers nearby and offers convenient access to major southside Jacksonville business and residential areas.

"The opening of our new Jacksonville pharmacy in northern Florida further diversifies and complements our growing footprint. As we continue to grow our healthcare operations, we see the opening of new locations and selective acquisitions of well-established pharmacies as the ideal way to bring our unique combination of retail and higher-margin contracted services to underserved communities across Florida," said David Phipps, CEO of NextPlat.

PharmcoRx, NextPlat's dedicated healthcare services unit, currently operates a growing network of six retail pharmacies serving patients across Florida providing full-service prescription fulfillment, medication management, high-touch, same day delivery, and integrated patient support. It also provides a full suite of high-margin contracted services for healthcare providers and institutions including 340B, long-term care facilities and government agencies. By combining retail, specialty, institutional, 340B and government services, PharmcoRx can serve multiple patient populations and healthcare partners through a single pharmacy operation, differentiating itself from the traditional mass-market pharmacy chains.

Rodney Barreto, Chairman of NextPlat Corp, added, "Our expansion into rapidly growing Jacksonville, Florida, enables us to bring our high-quality PharmcoRx services to another vibrant community as we continue to expand across the state. We believe there is growing demand for high-quality, patient-centric healthcare services such as those delivered by PharmcoRx, creating significant growth opportunities for us in the in the months ahead."

PharmcoRx's Jacksonville location will feature a full array of integrated pharmacy solutions including:

  • Full-service prescription fulfillment, medication management, delivery, patient support and coordination with healthcare providers.

  • Higher-margin contracted services for healthcare providers participating in the government's 340B discounted drug pricing program which supports poor or underserved populations such as children's and sole community hospitals, hemophilia diagnostic treatment centers, HIV/sexually transmitted disease and family planning clinics, with prescription fulfillment, inventory management, claims administration, compliance support and reporting services.

  • Services designed for long-term care, assisted living facilities, senior-care communities and other institutions including customized medication packaging, scheduled delivery, pharmacist oversight and medication administration support.

  • Specialty pharmacy service for patients receiving complex or high-cost therapies through specialized dispensing, education, adherence monitoring and coordination with prescribers and insurers.

By offering a full array of integrated pharmacy services, PharmcoRx can diversify its business model and reduce its reliance on any one customer channel, creating several avenues for sustainable, long-term growth.

Prompts

NextPlat Corp (ticker NXPL), listed in United States.

Company History

Date Change Detail
Jan 21, 2022 Renamed ORBSAT CORP → NEXTPLAT CORP
Aug 19, 2019 Renamed ORBITAL TRACKING CORP. → ORBSAT CORP
Jan 9, 2015 Renamed GREAT WEST RESOURCES, INC. → ORBITAL TRACKING CORP.
May 14, 2014 Renamed SILVER HORN MINING LTD. → GREAT WEST RESOURCES, INC.
May 3, 2011 Renamed ECLIPS MEDIA TECHNOLOGIES, INC. → SILVER HORN MINING LTD.
May 17, 2010 Renamed ECLIPS ENERGY TECHNOLOGIES, INC. → ECLIPS MEDIA TECHNOLOGIES, INC.
Mar 25, 2009 Renamed WORLD ENERGY SOLUTIONS, INC. → ECLIPS ENERGY TECHNOLOGIES, INC.
Nov 15, 2005 Renamed ADVANCED 3-D ULTRASOUND SERVICES INC → WORLD ENERGY SOLUTIONS, INC.
Aug 19, 2005 Renamed YSEEK INC → ADVANCED 3-D ULTRASOUND SERVICES INC
Apr 13, 2001 Renamed SWIFTY CARWASH & QUIK LUBE INC → YSEEK INC
— Predecessor Predecessor World Energy Solutions, Inc. (CIK 1371781) filed under its own registration; its figures are on its own company page, not shown here.
— Former tickers NXPLW

ETFs Holding NextPlat Corp

ETF Weight in ETF Shares Market value As of
DFSU 0.00% 1,435 $ 9,600.15 Nov 12, 2026
DCOR 0.00% 210 $ 1,404.90 Nov 12, 2026